Revista Brasileira de Hematologia e Hemoterapia (Jan 2009)

Aplasia medular após transplante hepático em pediatria Aplastic anemia after pediatric liver transplantation

  • Marlene P. Garanito,
  • Jorge D. A. Carneiro,
  • Maria Mercês Santos,
  • Nelson E. M. Gibelli,
  • Lucy A. Matsumoto,
  • Uenis Tannuri

Journal volume & issue
Vol. 31, no. 5
pp. 397 – 399

Abstract

Read online

A aplasia de medula é uma das mais raras (Aplastic anemia (AA) is one of the rarest (<1%) and most serious complications of liver transplantation for fulminant non-A, non-B and non-C hepatitis. It was first described in 1987 by Stock; the mechanism involved is an immunologically mediated condition secondary to an unknown viral infection. The disease is associated with a dismal prognosis. Spontaneous recovery from acquired AA is very rare however some patients (50-70%) recover after immunosuppressive therapy, such as Cyclosporin A (CsA) and Antithymocyte globulin (ATG), even after liver transplantation. Another treatment option is bone marrow transplantation. We report on a child who developed AA following liver transplantation for fulminant viral hepatitis that was treated with intensive immunosuppression including CsA and ATG and achieved complete recovery.

Keywords